Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1011467

CCCCCCCCCCCCCCCCCCN(C)Cc1ccccc1.Cl

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SIGMAR1 known ✓ Q99720 4/20 0.71
MAOB known ✓ P27338 4/20 0.58
MAOA known ✓ P21397 1/20 0.58
ACHE known ✓ P22303 5/20 0.57
KCNH2 known ✓ Q12809 1/20 0.53
HTR7 known ✓ P34969 1/20 0.52
CARM1 Q86X55 1/20 0.56
PRMT6 Q96LA8 1/20 0.56
PRMT8 Q9NR22 1/20 0.56
KDM4A O75164 2/20 0.55
KDM4C Q9H3R0 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4621618 1.00 SIGMAR1 (0.71) SIGMAR1MAOBMAOAACHECARM1
Hydrochloric Acid SCHEMBL631053 1.00 SIGMAR1 (0.71) SIGMAR1MAOBMAOAACHECARM1
Hydrochloric Acid SCHEMBL27860635 1.00 SIGMAR1 (0.71) SIGMAR1MAOBMAOAACHECARM1
Hydrochloric Acid SCHEMBL593114 1.00 SIGMAR1 (0.71) SIGMAR1MAOBMAOAACHECARM1
Hydrochloric Acid SCHEMBL11136311 1.00 SIGMAR1 (0.71) SIGMAR1MAOBMAOAACHECARM1
Hydrochloric Acid SCHEMBL1160865 1.00 SIGMAR1 (0.71) SIGMAR1MAOBMAOAACHECARM1
Hydrochloric Acid SCHEMBL28758749 1.00 SIGMAR1 (0.71) SIGMAR1MAOBMAOAACHECARM1
Hydrochloric Acid SCHEMBL11138206 1.00 SIGMAR1 (0.71) SIGMAR1MAOBMAOAACHECARM1
Ethane SCHEMBL27832435 0.98 SIGMAR1 (0.69) SIGMAR1MAOBMAOAACHECARM1
Hydrochloric Acid SCHEMBL441762 0.98 SIGMAR1 (0.69) SIGMAR1MAOBMAOAACHECARM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116043539-A Durable antibacterial antiviral agent for textiles, and preparation method and application thereof 中安宜和生物科技(北京)有限公司 2023-05-02 CN claimed
CN-112809874-B Production method of low-density flame-retardant mildew-proof formaldehyde-free addition fiberboard and fiberboard 广西三威家居新材股份有限公司 2023-02-28 CN claimed
CN-113070968-A Production method of low-odor aldehyde-free medium-density fiberboard 广西三威家居新材股份有限公司 2021-07-06 CN claimed
CN-112809874-A Production method of low-density flame-retardant mildew-proof formaldehyde-free addition fiberboard and fiberboard 广西三威林产工业有限公司 2021-05-18 CN claimed
CN-110066646-A A kind of oil base drilling fluid compound organic clay and its preparation method 中国地质大学(北京) 2019-07-30 CN claimed
CN-109459468-A A kind of machine oil highly sensitive conductive reinforcing aids and preparation method thereof 中山职业技术学院 2019-03-12 CN claimed
CN-105219481-B Automatic balance car lubricant composition and preparation method 中国石油化工股份有限公司 2019-02-01 CN claimed
CN-104017549-B One kind prepares high yield value oil base drilling fluid organoclay and preparation method thereof 浙江丰虹新材料股份有限公司 2017-11-28 CN claimed
CN-104711877-B Polyacrylonitrile fibre original position mineralising, water-saving and emission-reducing dyeing post-processing approach and auxiliary agent 西安工程大学 2017-03-15 CN claimed
CN-104695253-B Cellulose fibre mineralising degree of depth water-saving and emission-reducing dyeing post-processing approach and auxiliary agent in situ 西安工程大学 2017-01-04 CN claimed
WO-2010023561-A9 PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF ACTAVIS GROUP PTC EHF (IS) 2011-08-04 WO claimed
CN-101507902-B Preparation method of porous polyvinylidene fluoride alloy membrane for treating and recycling waste water SUZHOU MOHUA MATERIAL TECHNOLOGY CO LTD 2011-06-29 CN claimed
EP-2334679-A1 PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF Actavis Group PTC EHF (IS) 2011-06-22 EP claimed
CN-101544412-B Aquaculture water purifying agent and preparation method thereof ZHEJIANG CROWN TECHNOLOGY CO LTD 2011-01-12 CN claimed
EP-2268634-A2 PROCESSES FOR THE PREPARATION OF BOSENTAN AND RELATED COMPOUNDS USING NOVEL INTERMEDIATES Actavis Group PTC EHF (IS) 2011-01-05 EP claimed
WO-2010023561-A1 PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF ACTAVIS GROUP PTC EHF (IS) 2010-03-04 WO claimed
CN-101544412-A Aquaculture water purifying agent and preparation method thereof ZHEJIANG CROWN TECHNOLOGY CO L 2009-09-30 CN claimed
WO-2009112954-A2 PROCESSES FOR THE PREPARATION OF BOSENTAN AND RELATED COMPOUNDS USING NOVEL INTERMEDIATES ACTAVIS GROUP PTC EHF (IS) 2009-09-17 WO claimed
CN-101507902-A Preparation method of porous polyvinylidene fluoride alloy membrane for wastewater treatment and recycling SUZHOU MOHUA MATERIAL TECHNOLO (CN) 2009-08-19 CN claimed
CN-100398525-C Toluene diisocyanate trimer preparation method GUANGZHOU INST OF CHEMISTRY (CN) 2008-07-02 CN claimed